首页> 美国政府科技报告 >Stroma-Derived SDF-1 Confers Chemoresistance to CXCR4-Expressing Breast Cancer Cells; Final rept. 15 Sep 2006-14 Sep 2007
【24h】

Stroma-Derived SDF-1 Confers Chemoresistance to CXCR4-Expressing Breast Cancer Cells; Final rept. 15 Sep 2006-14 Sep 2007

机译:stroma衍生的sDF-1赋予CXCR4表达乳腺癌细胞化学抗性;最终的评论。 2006年9月15日至2007年9月14日

获取原文

摘要

The chemokine receptor CXCR4 is functionally expressed on the cell surface of various cancer cells, and plays a role in cell proliferation and migration of these cells. Specifically, in breast cancer cells the CXCR4/CXCL12 axis has been implicated in cell migration in vitro and in metastasis in vivo, but the underlying signaling mechanisms are incompletely understood. The xenograft-derived MDA-MB-231 breast cancer cell line (231mfp), which was shown previously to grow more aggressively than the parent cells, showed increased CXCR4 expression at the mRNA, total protein and cell surface expression level. This correlated with an enhanced response to CXCL12, specifically in augmented and prolonged Akt activation in a Gi, Src family kinase and PI-3 kinase dependent fashion. 231mfp cells migrated towards CXCL12 in contrast to the parent cell line and this chemotaxis was blocked by inhibition of Gi, Src family kinases, PI-3 kinase and interestingly, Akt itself, as could be shown with two pharmacological inhibitors, a dominant negative Akt construct and with Akt shRNA. Collectively, we have demonstrated that prolonged Akt activation is an important signaling pathway for breast cancer cells expressing CXCR4 and is necessary for CXCL12-dependent cell migration.

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号